Estudo descritivo epidemiológico e impacto na saúde mental e qualidade de vida em pacientes com fibromialgia de um Centro de Reumatologia

Carlos Alberto Marques Arêdes; Claudia  Correa Ribeiro; Midyan Ferreira Suhet; Bruna Bolzani Ribeiro; Carla Vasconcelos Caspar Andrade; Ketty Lysie Libardi Lira Machado; Marcelo Cruz Resende; Vinícius de Macedo Possamai; Eduardo dos Santos Paiva; Maria Bernadete R. de O. Gavi

doi:10.47456/rbps.v26isupl_1.44393

Authors

Carlos Alberto Marques Arêdes
Claudia Correa Ribeiro
Midyan Ferreira Suhet
Bruna Bolzani Ribeiro
Carla Vasconcelos Caspar Andrade
Ketty Lysie Libardi Lira Machado
Marcelo Cruz Resende
Vinícius de Macedo Possamai
Eduardo dos Santos Paiva
Maria Bernadete R. de O. Gavi

DOI:

https://doi.org/10.47456/rbps.v26isupl_1.44393

Keywords:

Fibromyalgia, Epidemiology, Quality of life, Database

Abstract

Introduction: Fibromyalgia (FM) is a chronic syndrome associated with fatigue, sleep, mood and cognitive disorders and generalized musculoskeletal pain. Objectives: Evaluate the clinical profile of patients with FM, the most used treatments and the impact of this syndrome through specific scales. Methods: Descriptive study based on data from records from the Epifibro 2.0 Project of patients treated in an outpatient clinic of a Rheumatology Service, who met the American College of Rheumatology Diagnostic Criteria of 2010 for FM. Data collection was carried out through the application of questionnaires from the Epifibro 2.0 Project with epidemiological data and specific scores to evaluate the impact of FM on patients in the pain outpatient clinic of a Rheumatology service. The data were stored in an Excel spreadsheet and analyzed using the SPSS 20.0 program. Results: 69 patients were evaluated, with a mean age of 58.27 ±9.62 years and a predominance of females at 94,2%. It was observed that 59.4% of patients had been diagnosed for more than 10 years, 92.8% had completed high school and 86.7% had a family income greater than 3 minimum wages. The most prescribed medications were pregabalin and fluoxetine, whereas the most recommended non-pharmacological treatments were aerobic exercises. The means of the PDS, FIQR, GAD-7, PHQ-9 questionnaires were moderate to severe. Conclusion: The patients analyzed had long-lasting illness and the most prescribed treatment was pharmacological treatment associated with aerobic exercise. The questionnaires demonstrated a population with moderate to severe impact on mental health and quality of life.

Downloads

Download data is not yet available.

References

Paiva ES, Martinez JE, Heymann RE. Fibromialgia. In: Moreira C, Shinjo SK, editors. Livro da Sociedade Brasileira de Reumato¬logia. 3rd ed. São Paulo: Editora Manole; 2023. p. 272-77.

Clauw DJ. Fibromyalgia and related syndromes. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, edi¬tors. Rheumatology. 5th ed. Philadelphia: Mosby Elsevier; 2011. p. 769-82.

Smythe HA, Moldofsky H. Two contributions to understanding of the “fibrositis’’ syndrome. Bull Rheum Dis. 1977;28:928-31.

Heymann RE, Paiva ES, Martinez JE, Rezende MC, Provenza JR, et al. Nova Diretriz para diagnóstico de fibromialgia. Rev Bras Reumatol. 2017;57(S2):S467–S476.

Athayde IB, Marques ETF, Côrtes JPR. Uma abordagem geral da fibromialgia: revisão da literatura. REAMed. 2022;17:1-6.

Yunus M, Masi EM, Calabro JJ, Miller KA, Feigenbaum SL. Pri¬mary Fibromyalgia (Fibrositis) Clinical Study of 50 Patients with Matched Controls. Sem Arthr Rheum. 1981;11(1):151–71.

Provenza JR, Pollak DF, Martinez JE, Paiva ES, Helfenstein M, Heymann R, et al. Projeto Diretriz Fibromialgia. Sociedade Bra¬sileira de Reumatologia. 2004;1-13.

Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-72.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology prelim¬inary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600-10.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;45(3):319-29.

Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995 Jan;38(1):19-28.

Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, et al. Prevalence of rheumatic diseases in Bra¬zil: a study using the COPCORD approach. J Rheumatol. 2004 Mar;31(3):594-7.

Martinez JE, Paiva ES, Rezende MC, Heymann RE, Junior MH, Ranzolin A, et al. EpiFibro (Registro Brasileiro de Fibromial¬gia): dados sobre a classificação do ACR e preenchimento dos critérios diagnósticos preliminares e avaliação de seguimento. Rev Bras Reumatol. 2017;57(2):129–33.

Heymann RE, Paiva ES, Junior MH, Pollak DF, Martinez JF, Provenza JR, et al. Consenso brasileiro de tratamento de fibro¬mialgia. Rev Bras Reumatol. 2010;50(1):56-66.

Wolfe F, Walitt B, Perrot S, Rasker JJ, Häuser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One. 2018 Sep 13;13(9):e0203755.

Rezende MC, Paiva ES, Junior MH, Ranzolin A, Martinez JE, Provenza JP, et al. EpiFibro – um banco de dados nacional sobre a síndrome da fibromialgia – análise inicial de 500 mulheres. Rev Bras Reumatol. 2013 Oct;53(5):382–387.

Assis MR, Paiva ES, Junior MH, Heymann RE, Pollak DF, Provenza JR, et al. Dados de tratamento do Registro Brasileiro de Fibromialgia (EpiFibro). Advances in Rheumatology. 2020;60:1-5.

Cao QW, Peng BG, Wang L, Huang VQ, Jia DL, Jiang H, et al. Expert consensus on the diagnosis and treatment of myofascial pain syndrome. World J Clin Cases. 2021 Mar 26;9(9):2077-89.

Gequelim GC, Dranka D, Furlan JA, Mejia MM, Paiva ES. Estudo clínico-epidemiológico de fibromialgia em um hospital universi¬tário do Sul do Brasil. Rev Bras Clin Med São Paulo. 2013 Oct- Dec;11(4):344-9.

Júnior JO de O, Almeida MB. The current treatment of fibromy¬algia. Br J Pain. São Paulo. 2018 Jul-Sep;1(3):255-62.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluss E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–28.

Atzeni F, Talotta R, Masala S, Giacomelli C, Conversano C, Nucera V, et al. Fibromyalgia: One Year Review 2019. Clin Exp Rheumatol. 2019 Jan-Feb;116(1):3-10.

Collado A, Rivera J, Alegre C, Casanueva B, et al. Fibromy¬algia: Old opinions versus new knowledge. Reumatol Clin. 2021;17(9):554-7.

Filho MAGO, Assis MR. Tratamento não farmacológico da fibromialgia. In: Braz AS, Ranzolin A, Heymann RE, editors. Dor Musculoesqueléticas Localizadas e Difusas. 3rd ed. Barueri [SP]: Editora Manole; 2022. p. 99-123.

Marques AP, Santos AMB, Assumpção A, Matsutani LA, Lage LV, Pereira CAB. Validation of the Brazilian Version of the Fibromyalgia Impact Questionnaire (FIQ). Rev Bras Reumatol. 2006;46(1):24-31.